Anthropic acquires AI biotech to advance rare pediatric drug
Anthropic announced it acquired a one-person biotech company using Claude to research rare pediatric muscular dystrophies. The move expands Anthropic's capabilities in AI-driven biotechnology.
Summarized by AI from 3 outlets
Source
- iThomeRead original ↗
- ITmedia NEWSRead original ↗
- INSIDERead original ↗
Latest
- Funding
OpenAI Raises Less Than Half of $30B Target
OpenAI raised less than half of its $30 billion funding target. This shortfall indicates challenges in securing massive capital, which may impact future development plans.
Hacker NewsIT之家INSIDE3 outlets
- Funding
Nvidia Weighs Cosigning Loan for Nscale AI Data Center
Nvidia is reportedly considering co-signing a loan for Nscale's AI data center in West Virginia. This move aims to alleviate investor concerns about AI infrastructure spending and reinforce the company's commitment to the AI compute ecosystem.
- Funding
ByteDance's Zhou Chang Leaves for Physical AI Startup
Zhou Chang, a key leader at ByteDance's Seed, left to start a physical AI venture backed by a top US fund. He previously led technical teams for Tongyi Qianwen and ByteDance's vision models.
- Funding
Kuaishou's Kling AI Completes $2.9B Capital Increase
Kuaishou's Kling AI completed a capital increase of about 19.8 billion RMB ($2.9 billion). The final amount was slightly below the cap, with investors including national funds and Alibaba Cloud, resulting in a post-money valuation of roughly 120 billion RMB.
- Funding
Cracks in AI Spending Boom: Debt and Negative Cash Flow Raise Doubts
Big Tech is pouring billions into AI infrastructure, but mounting debt, negative cash flow, and waning investor confidence are questioning the sustainability of the AI spending boom, reflecting industry financial pressure.
All news → · All rights belong to the original creators